400-920-2911 sales@csnpharm.cn
货号 | 产品名 | CAS号 | 信息 |
---|---|---|---|
CSN25874 | VLX600 | 327031-55-0 | VLX600 is a novel iron-chelating inhibitor of oxidative phosphorylation, potentiated the effect of radiation in tumor spheroids in a synergistic manner. VLX600 is preferentially active against quiescent cells in colon cancer 3-D microtissues. VLX600 shows enhanced cytotoxic activity under conditions of nutrient starvation and displays tumour growth inhibition in vivo. |
CSN24077 | S-Gboxin | 2101317-21-7 | S-Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. |
CSN21365 | IACS-010759 | 1570496-34-2 | IACS-010759 is a potent and selective inhibits oxidative phosphorylation with IC50 < 10 nM. It also binds to and inhibits complex I of the electron transport chain (NADH ubiquinone oxidoreductase), selectively depriving tumor cells of nutrients and energy, inhibiting nucleotide and amino acid production, and induces autophagy. |
CSN26721 | IACS-010759 hydrochloride | 1807523-99-4 | IACS-010759 or IACS-10759 is a potent inhibitor of complex I of OXPHOS. IACS-10759 effectively inhibits ATP production and oxygen consumption in isolated mitochondria, and inhibits the conversion of NADH to NAD+ in immunoprecipitated complex I in low nM range. IACS-10759 is orally bioavailable with excellent physicochemical properties in preclinical species, and shows significant efficacy in multiple tumor indications both in vitro and in vivo. IACS-10759 causes robust tumor regression, but has no effect in the same model when glycolysis is restored. |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网